
EPH receptor A4 - Wikipedia
EPH receptor A4 (ephrin type-A receptor 4) is a protein that in humans is encoded by the EPHA4 gene. [5] [6] This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system.
EPHA4 Gene - GeneCards | EPHA4 Protein | EPHA4 Antibody
2024年12月25日 · EPHA4 (EPH Receptor A4) is a Protein Coding gene. Diseases associated with EPHA4 include Gaba Aminotransferase Deficiency and Opitz-Kaveggia Syndrome. Among its related pathways are GPCR Pathway and ERK Signaling. Gene Ontology (GO) annotations related to this gene include identical protein binding and protein kinase activity.
Unraveling the Potential of EphA4: A Breakthrough Target and
2023年7月21日 · Erythropoietin-producing hepatocellular carcinoma A4 (EphA4) is a transmembrane receptor protein which is a part of the most prominent family of receptor tyrosine kinases (RTKs). It serves a crucial role in both physiological, biological, and functional states binding with their ligand like Ephrins.
Unraveling the Potential of EphA4: A Breakthrough Target and
Erythropoietin-producing hepatocellular carcinoma A4 (EphA4) is a transmembrane receptor protein which is a part of the most prominent family of receptor tyrosine kinases (RTKs). It serves a crucial role in both physiological, biological, and …
Identification and characterization of Nanobodies targeting the EphA4 …
The ephrin receptor A4 (EphA4) is one of the receptors in the ephrin system that plays a pivotal role in a variety of cell-cell interactions, mostly studied during development. In addition, EphA4 has been found to play a role in cancer biology as ...
EPHA4 is a disease modifier of amyotrophic lateral sclerosis
2012年8月26日 · Here, we have screened a zebrafish model of ALS and identified Epha4, a receptor in the ephrin axonal repellent system, as a modifier of the disease phenotype in fish, rodents and humans.
EPHA4 is a disease modifier of amyotrophic lateral sclerosis
Here, we have screened a zebrafish model of ALS and identified Epha4, a receptor in the ephrin axonal repellent system, as a modifier of the disease phenotype in fish, rodents and humans. Genetic as well as pharmacological inhibition of Epha4 signaling rescues the mutant SOD1 phenotype in zebrafish and increases survival in mouse and rat models ...
2043 - Gene ResultEPHA4 EPH receptor A4 [ (human)]
EphA4 gene expression is associated with an improved outcome in patients with resected lung adenocarcinoma, possibly by affecting cancer cell migration and invasion. Epha4 modulates the vulnerability of motor neurons to axonal degeneration and may represent a new target for therapeutic intervention in ALS.
EphA4 targeting agents protect motor neurons from cell death …
2022年9月2日 · Here we found that first-generation synthetic EphA4 agonistic agent 123C4, effectively protected MNs when co-cultured with reactive astrocytes from patients with ALS from multiple subgroups (sALS and mutant SOD1).
Epha4 Eph receptor A4 [ (house mouse)] - National Center for ...
2025年2月8日 · The EphA4 Signaling is Anti-catabolic in Synoviocytes but Pro-anabolic in Articular Chondrocytes. EphA4 Is Required for Neural Circuits Controlling Skilled Reaching. Inducible EphA4 knockout causes motor deficits in young mice and is not protective in the SOD1(G93A) mouse model of ALS.